# Assessment of Continuous Measurement of Transcutaneous CO2 for Evaluation of Alveolar Dead Space During Exercise

> **NCT03718780** · NA · UNKNOWN · sponsor: **Centre Hospitalier Metropole Savoie** · enrollment: 105 (estimated)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive
- Lung Diseases, Interstitial
- Chronic Heart Failure
- Pulmonary Arterial Hypertension
- Hyperventilation Syndrome
- Healthy

## Interventions

- **OTHER:** simultaneous determination of PaCO2 and PtCO2
- **OTHER:** Hyperventilation test
- **OTHER:** Exercise test

## Key facts

- **NCT ID:** NCT03718780
- **Lead sponsor:** Centre Hospitalier Metropole Savoie
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-02-22
- **Primary completion:** 2024-02-22
- **Final completion:** 2024-02-22
- **Target enrollment:** 105 (ESTIMATED)
- **Last updated:** 2022-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03718780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03718780, "Assessment of Continuous Measurement of Transcutaneous CO2 for Evaluation of Alveolar Dead Space During Exercise". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03718780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*